Skip to content

Evidence-based summary of the construction and initial application of an exercise programme for COPD patients

Evidence-based summary of the construction and initial application of an exercise programme for COPD patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084698
Enrollment
Unknown
Registered
2024-05-23
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

Test group:A structured COPD exercise programme based on conventional treatment and care

Sponsors

Hainan medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 diagnostic criteria: chronic cough and sputum with progressive dyspnoea; history of COPD risk factor exposure; FEV1/FVC <70% after inhaled bronchodilators. (2) Adult, aged =40 years. (3) Can communicate in Mandarin. (4) Voluntary participation.

Exclusion criteria

Exclusion criteria: (1) Combined with other diseases of the respiratory system: multiple pulmonary blisters in both lungs, severe pulmonary hypertension (resting pulmonary pulse pressure > 45 mmHg), acute pulmonary embolism or infarction, spontaneous or recurrent pneumothorax within the last month, etc. (2) Patients with disorientation, patients with severe psychiatric or neurological disorders. (3) Combined serious cardiovascular disease: acute myocardial infarction (3-5 days), unstable angina, uncontrolled heart rate (>120 beats/min), uncontrolled hypertension (systolic blood pressure above 180 mmHg, diastolic blood pressure above 100 mmHg), etc. (4) Other physical conditions: non-cardiac conditions (infection, renal failure, haemorrhage, severe renal disease including dialysis, renal transplantation) affecting the ability to exercise or caused by exercise, entrapment aneurysm, blood clots in the lower limbs, high visual impairment, etc. Fulfilling any of the exclusion criteria will exclude you from this study.

Design outcomes

Primary

MeasureTime frame
Pulmonary function indicators (FVC (exertional spirometry), FEV1 (first second exertional expiratory volume), FEV1/FVC (one second exertional expiratory volume/exertional spirometry));Simple Body Assessment;Modified dyspnoea score (mMRC);Grip strength;

Secondary

MeasureTime frame
Pulmonary function indicators (FVC (exertional spirometry), FEV1 (first second exertional expiratory volume), FEV1/FVC (one second exertional expiratory volume/exertional spirometry));

Countries

China

Contacts

Public ContactCaihong Zhang, Ziwei Zhang

Hainan medical university

1453422748@qq.com+86 136 4868 0378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026